Cargando…

Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer

Immunotherapy for skin malignancies has ushered in a new era for cancer treatments by demonstrating unprecedented durable responses in the setting of metastatic Melanoma. Consequently, checkpoint inhibitors are now the first-line treatment of metastatic melanoma and widely used as adjuvant therapy f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bridge, Jennifer A., Lee, James C., Daud, Adil, Wells, James W., Bluestone, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315146/ https://www.ncbi.nlm.nih.gov/pubmed/30631766 http://dx.doi.org/10.3389/fmed.2018.00351

Ejemplares similares

Editorial: Insights Into Biomarkers, Cytokines, and Chemokines in Skin Cancer
por: Barrett, Lucy W., et al.
Publicado: (2019)

The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
por: Kuo, Paula T., et al.
Publicado: (2018)

The gut microbiota and immune checkpoint inhibitors
por: Humphries, Audrey, et al.
Publicado: (2018)

Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases
por: Liu, Timothy J., et al.
Publicado: (2022)

Causes of Pruritus in Patients Treated With Immune Checkpoint Inhibitors for Melanomas or Skin Carcinomas
por: Salinas, Nadia, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Lung Cancer: Role of Biomarkers and Combination Therapies
por: Maung, Tun Zan, et al.
Publicado: (2020)

Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
por: Nakamura, Yoshiyuki
Publicado: (2019)

Cytokine/chemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stage
por: Tuong, Zewen K., et al.
Publicado: (2019)

Cytokines and Chemokines as Biomarkers of Future Asthma
por: Bush, Andrew
Publicado: (2019)

Cytokine and Chemokine Concentrations as Biomarkers of Feline Mycobacteriosis
por: O’Halloran, C., et al.
Publicado: (2018)

Response to Immune Checkpoint Inhibitor Treatment in Advanced Cervical Cancer and Biomarker Study
por: Shieh, Kevin R., et al.
Publicado: (2021)

Cytokines and Chemokines as Biomarkers of Community-Acquired Bacterial Infection
por: Holub, Michal, et al.
Publicado: (2013)

Dataset-chemokines, cytokines, and biomarkers in the saliva of children with Sjögren's syndrome
por: Withanage, Miyuraj Harishchandra Hikkaduwa, et al.
Publicado: (2021)

Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study
por: Gómez-Puerta, José A., et al.
Publicado: (2022)

The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity
por: Moss, Emily M., et al.
Publicado: (2022)

Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
por: Butner, Joseph D, et al.
Publicado: (2021)

Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center
por: Kurzhals, Jonas K., et al.
Publicado: (2021)

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
por: Stamatouli, Angeliki M., et al.
Publicado: (2018)

Proinflammatory Cytokines and Chemokines at the Skin Interface during Powassan Virus Transmission
por: Hermance, Meghan E, et al.
Publicado: (2014)

New biomarkers for checkpoint inhibitor therapy
por: Burdett, Nikki, et al.
Publicado: (2020)

Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences
por: Cardeña-Gutiérrez, Ana, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis
por: Pagan, Andrea, et al.
Publicado: (2020)

Chemokines and Cytokines as Salivary Biomarkers for the Early Diagnosis of Oral Cancer
por: Prasad, Gareema, et al.
Publicado: (2013)

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
por: Quagliariello, Vincenzo, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and the Heart
por: Mocan-Hognogi, Diana Larisa, et al.
Publicado: (2021)

Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge
por: Catalano, Martina, et al.
Publicado: (2022)

Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis
por: Nedoszytko, Bogusław, et al.
Publicado: (2014)

Cytokines and Chemokines in Periodontitis
por: Ramadan, Doaa Elsayed, et al.
Publicado: (2020)

Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
por: Quagliariello, Vincenzo, et al.
Publicado: (2023)

A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
por: Gomez Hernandez, M Paula, et al.
Publicado: (2021)

Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysis
por: Fitzsimmons, Timothy S., et al.
Publicado: (2023)

Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non‐small cell lung cancer
por: Hu, Yue, et al.
Publicado: (2023)

Objective response to immune checkpoint inhibitor therapy in NRAS-mutant melanoma: A systematic review and meta-analysis
por: Jaeger, Zachary J., et al.
Publicado: (2023)

Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients
por: Vang, Anna R., et al.
Publicado: (2023)

Cytokines and Chemokines: Disease Models, Mechanisms, and Therapies
por: Ahmed, Salahuddin, et al.
Publicado: (2014)

Molecular imaging biomarkers for immune checkpoint inhibitor therapy
por: van de Donk, Pim P, et al.
Publicado: (2020)

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
por: Coureau, Michelle, et al.
Publicado: (2020)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Shen, Pan, et al.
Publicado: (2021)

Cutaneous angiosarcoma: A review of current evidence for treatment with checkpoint inhibitors
por: Guan, Lucy, et al.
Publicado: (2023)

Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult Dermatomyositis
por: Crowson, Cynthia S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sofe63pi59naoatg57ovv6taqf